X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-05 | IMGN | Coen Stacy Ann | SVP, Chief Business Officer | S - Sale+OE | $29.30 | -4,583 | 73,274 | -6% | -$134,282 | |||||
| D | 2024-02-05 | IMGN | Wingrove Theresa | SVP of Regulatory Affairs | S - Sale+OE | $29.30 | -12,027 | 21,039 | -36% | -$352,391 | |||||
| D | 2024-02-05 | IMGN | Enyedy Mark J | CEO | S - Sale+OE | $29.28 | -20,107 | 584,397 | -3% | -$588,733 | |||||
| D | 2024-02-05 | IMGN | Lentini Renee | VP, PRIN ACCTG OFFICER | S - Sale+OE | $29.30 | -2,631 | 14,723 | -15% | -$77,088 | |||||
| D | 2024-01-16 | IMGN | Wingrove Theresa | SVP of Regulatory Affairs | S - Sale+OE | $29.64 | -187,667 | 3,426 | -98% | -$5,562,450 | |||||
| D | 2023-12-26 | IMGN | Lentini Renee | VP, PRIN ACCTG OFFICER | S - Sale+OE | $29.74 | -6,548 | 8,452 | -44% | -$194,738 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |